Historical shareholding details of TD US Mid-Cap Growth Fund holdings in CRISPR Therapeutics AG (CRSP)

Monthly changes of TD US Mid-Cap Growth Fund shareholding in CRISPR Therapeutics AG over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Td Us Mid-Cap Growth Fund 114,208 0.13%
Jun 30, 2024 Td Us Mid-Cap Growth Fund 73,808 0.09%
Dec 31, 2023 Td Us Mid-Cap Growth Fund 83,414 0.10%
Jun 30, 2023 Td Us Mid-Cap Growth Fund 83,414 0.10%
Dec 31, 2022 Td Us Mid-Cap Growth Fund 71,214 0.09%

View all ownership details of CRISPR Therapeutics AG